Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 29 Similar Profiles
Cystic Fibrosis
Medicine & Life Sciences
Type 1 Diabetes Mellitus
Medicine & Life Sciences
Insulin Resistance
Medicine & Life Sciences
Insulin
Medicine & Life Sciences
Glucose
Medicine & Life Sciences
Pancreatectomy
Medicine & Life Sciences
Fasting
Medicine & Life Sciences
C-Peptide
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1995 2022
Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type I Diabetes: A Proof-of-Concept Study
Juvenile Diabetes Research Foundation
9/1/19 → 8/31/22
Project: Research project
Cell- and Tissue-Based Therapy
Type 1 Diabetes Mellitus
A prospective, multi-center, Phase 1b/2a study to assess the safety and tolerability of different doses ofAG019 administered alone or in association with teplizumab in subjects with clinical recent-onset Type 1Diabetes Mellitus (T1D).
7/1/18 → 7/31/22
Project: Research project
Type 1 Diabetes Mellitus
Safety
teplizumab
TYPE 1 DIABETES EXTENSION STUDY (TIDES)
BENAROYA RESEARCH INST AT VIRGINIA MASON
2/1/17 → 1/31/20
Project: Research project
Regulatory T-Lymphocytes
Placebos
Clinical Trials
Safety
Research Output 1989 2019
Continuous glucose monitoring in cystic fibrosis – A practical guide
Chan, C. L., Ode, K. L., Granandos, A., Moheet, A., Moran, A. & Hameed, S., Jan 1 2019, (Accepted/In press) In : Journal of Cystic Fibrosis.Research output: Contribution to journal › Article
Cystic Fibrosis
Glucose
Aptitude
Blood Glucose Self-Monitoring
Technology
Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment
Moheet, A., Chan, C. L., Granados, A., Ode, K. L., Moran, A. & Battezzati, A., Jan 1 2019, In : Journal of Cystic Fibrosis.Research output: Contribution to journal › Article
Hypoglycemia
Cystic Fibrosis
Therapeutics
Insulin
Glucose Tolerance Test
2
Citations
(Scopus)
Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: Two-year clinical trial data
Type 1 Diabetes TrialNet ATG-GCSF Study Group, Jun 1 2019, In : Diabetes. 68, 6, p. 1267-1276 10 p.Research output: Contribution to journal › Article
Open Access
Antilymphocyte Serum
C-Peptide
Type 1 Diabetes Mellitus
Clinical Trials
T-Lymphocytes
Nutrition and growth considerations in CFRD
Kaminski, B. A., Goldsweig, B. K., Sidhaye, A., Blackman, S., Schindler, T. & Moran, A., Jan 1 2019, (Accepted/In press) In : Journal of Cystic Fibrosis.Research output: Contribution to journal › Article
Cystic Fibrosis
Growth
Nutritional Status
Blood Glucose
Carbohydrates
Pathophysiology, screening and diagnosis of cystic fibrosis related diabetes
Granados, A., Chan, C. L., Larson Ode, K., Moheet, A., Moran, A. & Holl, R., Jan 1 2019, (Accepted/In press) In : Journal of Cystic Fibrosis.Research output: Contribution to journal › Article
Cystic Fibrosis
Glucose Tolerance Test
Natural History
Islets of Langerhans
Early Diagnosis